Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Green, Benjamin J ^a   Wiriyachaiporn, Surasa ^b   Grainge, Christopher ^a,c   Rogers, Geraint B ^b,d   Kehagia, Valia ^a   Lau, Rie ^a   Carroll, Mary P ^a   Bruce, Kenneth D ^b   Howarth, Peter H ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c JOHN HUNTER HOSPITAL   (Australia)

^d SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; ASTHMA; BACTERIAL COLONIZATION; BACTERIAL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS; HUMAN; MALE; MICROBIAL COMMUNITY; MORAXELLA CATARRHALIS; NEUTROPHIL COUNT; RESPIRATORY TRACT INFLAMMATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPUTUM ANALYSIS; STREPTOCOCCUS; AIRWAY OBSTRUCTION; BACTERIUM; COMPLICATION; FOLLOW UP; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NEUTROPHIL; PATHOGENICITY; PATHOLOGY; PHENOTYPE; PROGNOSIS; RESPIRATORY SYSTEM; SPUTUM;

ADULT; AGED; AIRWAY OBSTRUCTION; ASTHMA; BACTERIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MALE; MIDDLE AGED; NEUTROPHILS; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; RESPIRATORY SYSTEM; SPUTUM;

EID: 84903553827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100645     Document Type: Article

References (34)

1. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, et al. (2011) Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 127: 372-381.e1-3. doi:10.1016/j.jaci.2010.10.048
2. Marri PR, Stern DA, Wright AL, Billheimer D, Martinez FD (2013) Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol 131: 346-52.e1-3. doi:10.1016/j.jaci.2012.11.013
3. Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, et al. (2013) The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 188: 1193-1201. doi:10.1164/rccm.201304-0775OC
4. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, et al. (2010) Disordered microbial communities in asthmatic airways. PLoS ONE 5: e8578. doi:10.1371/journal.pone.0008578
5. Szefler SJ, Zeiger RS, Haselkorn T, Mink DR, Kamath TV, et al. (2011) Economic burden of impairment in children with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 107: 110-119.e111. doi:10.1016/j.anai.2011. 04.008
6. Breekveldt-Postma NS, Erkens JA, Aalbers R, van de Ven MJT, Lammers J-WJ, et al. (2008) Extent of uncontrolled disease and associated medical costs in severe asthma-a PHARMO study. Curr Med Res Opin 24: 975-983. doi:10.1185/030079908X280518 (Pubitemid 351579154)
7. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, et al. (1999) Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160: 1532-1539.
8. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ (1999) Non-eosinophilic corticosteroid unresponsive asthma. Lancet 353: 2213-2214. doi:10.1016/S0140- 6736(99)01813-9 (Pubitemid 29295261)
9. Bacci E, Cianchetti S, Bartoli M, Dente FL, Di Franco A, et al. (2006) Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. Chest 129: 565-572. doi:10.1378/chest.129.3.565
10. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, et al. (2002) Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57: 875-879. (Pubitemid 35178612)
11. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, et al. (2007) Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62: 211-218. doi:10.1136/thx.2006.061358 (Pubitemid 46579799)
12. Gibson PG, Simpson JL, Saltos N (2001) Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119: 1329-1336. (Pubitemid 32686012)
13. Yang IA, Fong KM, Holgate ST, Holloway JW (2006) The role of Toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol 6: 23-28. doi:10.1097/01.all.0000200503.77295.bb (Pubitemid 44517805)
14. Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, et al. (2005) Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60: 1012-1018. doi:10.1136/thx.2005. 045260 (Pubitemid 41705469)
15. Stressmann FA, Rogers GB, van der Gast CJ, Marsh P, Vermeer LS, et al. (2012) Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 67: 867-873. doi:10.1136/thoraxjnl-2011- 200932
16. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, et al. (2004) characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 42: 5176-5183. doi:10.1128/JCM.42.11. 5176-5183.2004 (Pubitemid 39506227)
17. Rogers GB, Hart CA, Mason JR, Hughes M, Walshaw MJ, et al. (2003) Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 41: 3548-3558. (Pubitemid 36994681)
18. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. (2000) Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Vol. 162. pp. 2341-2351.
19. British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) British Guideline on the Management of Asthma. Thorax 63 Suppl 4: iv1-iv121. doi:10.1136/thx.2008.097741
20. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, et al. (2002) Sputum induction. The European respiratory journal Supplement 37: 3s-8s. (Pubitemid 35024261)
21. Rogers GB, Zain NMM, Bruce KD, Burr LD, Chen AC, et al. (2014) A Novel Microbiota Stratification System Predicts Future Exacerbations in Bronchiectasis. Ann Am Thorac Soc. doi:10.1513/AnnalsATS.201310-335OC.
22. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, et al. (2007) Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 357: 1487-1495. doi:10.1056/NEJMoa052632 (Pubitemid 47572634)
23. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS (2006) Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173: 991-998. doi:10.1164/rccm. 200509-1525OC
24. Wilkinson TMA, Patel IS, Wilks M, Donaldson GC, Wedzicha JA (2003) Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1090-1095. doi:10.1164/rccm.200210- 1179OC (Pubitemid 36459654)
25. Banerjee D, Khair OA, Honeybourne D (2004) Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J 23: 685-691. (Pubitemid 38618136)
26. Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen SJ, Donaldson GC, et al. (2002) Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57: 759-764. (Pubitemid 34984972)
27. Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, et al. (2013) Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 68: 731-737. doi:10.1136/thoraxjnl- 2012-203105
28. Rogers GB, Skelton S, Serisier DJ, van der Gast CJ, Bruce KD (2010) Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling. J Clin Microbiol 48: 78-86. doi:10.1128/JCM.01324-09
29. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, et al. (1996) Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 154: 308-317. (Pubitemid 26269096)
30. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, et al. (2006) Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 44: 2601-2604. doi:10.1128/JCM.02282-05 (Pubitemid 44092439)
31. Cabrera-Rubio R, Garcia-Núñez M, Setó L, Antó JM, Moya A, et al. (2012) Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J Clin Microbiol 50: 3562-3568. doi:10.1128/JCM.00767-12
32. Richeldi L, Ferrara G, Fabbri LM, Lasserson TJ, Gibson PG (2005) Macrolides for chronic asthma. Cochrane Database Syst Rev: CD002997. doi:10.1002/14651858.CD002997.pub3
33. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG (2008) Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 177: 148-155. doi:10.1164/rccm.200707-1134OC
34. Brusselle GG, Vanderstichele C, Jordens P, Deman R, Slabbynck H, et al. (2013) Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax. doi:10.1136/thoraxjnl-2012-202698